Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04444349 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Protective Effect of CoQ10 Against Negative Inflammatory Response and Organ Dysfunction in Cardiovascular Surgery (PANDA V)

Study acronym: PANDA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 27, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jul 1, 2020 to Feb 1, 2021
    • Study sites: 3 to 4
    • Collaborators expanded, about 22 words
    v4
  2. Re-verified, no change to tracked fieldsv3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 6 more changesShow less
    • Enrollment target: 300 to 500
    • Primary and study completion dates: Dec 31, 2022 to Dec 31, 2025
    • Start date changed from estimate of Aug 1, 2020 to Jul 1, 2020
    • Interventions: Coenzyme Q10 (Drug), Placebo (Dietary Supplement) to Coenzyme Q10 (Drug), Standard Medical Therapy (Dietary Supplement)
    • Eligibility criteria expanded, about 10 words
    • Study title expanded, about 7 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Cardiovascular diseases are the leading causes of death and prescription drug use. Research on certain dietary supplements looks promising as a way to help reduce risk factors. Previous studies showed that CoQ10 levels were decreased in cardiovascular patients and worsening of mitochondrial dysfunction was observed. The overall objective of this study is to determine if supplementing with CoQ10 can reduce inflammatory risk factors in adults with cardiac surgery, independent of other dietary or physical activity changes.
Trial Details
NCT Number NCT04444349
Lead Sponsor Nanjing Medical University
Collaborators: The First Affiliated Hospital with Nanjing Medical University, Beijing Anzhen Hospital, West China Hospital, The First Affiliated Hospital of Guangzhou Medical University
Conditions
(from sponsor)		 Cardiovascular Disease
Related terms Cardiovascular Diseases
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov